Deglycosylation of serum vitamin D3-binding protein by α-N-acetylgalactosaminidase detected in the plasma of patients with systemic lupus erythematosus

Clinical Immunology and Immunopathology

Volumn 82, Issue 3, 1997, Pages 290-298

  Yamamoto, Nobuto ^a   Naraparaju, Venkateswara R ^a   Moore, Mary ^b   Brent, Lawrence H ^b  

^a ALBERT EINSTEIN CANCER CENTER   (United States)

^b ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA N ACETYLGALACTOSAMINIDASE; BETA GALACTOSIDASE; COLECALCIFEROL; GLYCOPROTEIN; MACROPHAGE ACTIVATING FACTOR; SIALIDASE; VITAMIN D BINDING PROTEIN;

ARTICLE; CONTROLLED STUDY; DEGLYCOSYLATION; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PLASMA; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0031105365     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.4320     Document Type: Article

References (26)

1. 1. Jawetz, E., Melnick, J. L., and Adelberg, E. A., Antibody-mediated and cell-mediated reaction. In "Review of Medical Microbiology," 14th ed., pp. 175-189, Lange Medical Publication, Los Altos, CA, 1980.
2. 2. Roitt, I, Brostoff, J., and Male, D., Hypersensitivity-type III. In "Immunology," pp. 211-219, Gower Medical Publishing, New York, 1985.
3. 3. Goerke, J., de Gier, J., and Bensen, P. P. M., Silica gel stimulates the hydrolysis of lecithin by phospholipase A. Biochim. Biophys. Acta 248, 283-248, 1971.
4. 4. Munder, P. G., Modelell, M., Andreesen, R., Weltzien, H. U., and Westphal, O., Lysophosphatidylcholine (Lysolecithin) and its synthetic analogs, immuno-modulating and other biological effects. In "Immunomodulating: Springer Seminar on Immunopathology" (L. Chedid, P. A. Miescher, and H. J. Mueller-Eberhard, Eds.), Vol. 2, Nos. 1-2, pp. 177-193, Springer-Verlag, Berlin, 1980.
5. 5. Ngwenya, B. Z., and Yamamoto, N., Activation of peritoneal macrophages by lysophosphatidylcholine. Biochim. Biophys. Acta 839, 9-15, 1985.
6. 6. Ngwenya, B. Z., and Yamamoto, N., Effects of inflammation products on immune systems: Lysophosphatidylcholine stimulates macrophages. Cancer Immunol. Immunother. 21, 174-182, 1986.
7. 7. Yamamoto, N., and Ngwenya, B. Z., Activation of macrophages by lysophospholipids, and ether derivatives of neutral lipids and phospholipids. Cancer Res. 47, 2008-2013, 1987.
8. 8. Ngwenya, B. Z., and Yamamoto, N., Contribution of lysophosphatidylcholine treated nonadherent cells to mechanism of macrophage stimulation. Proc. Soc. Exp. Biol. Med. 193, 118-124, 1990.
9. 3-binding protein and albumin. Infect. Immun. 61, 5388-5391, 1993.
10. 10. Yamamoto, N., Willett, N. P., and Lindsay, D. D., Participation of serum proteins in the inflammation-primed activation of macrophages. Inflammation 18, 311-322, 1994.
11. 3-binding protein and immunosuppression in HIV-infected patients. AIDS Res. Hum. Retrospect. 11, 1373-1378, 1995.
12. 12. Yamamoto, N., Naraparaju, V. R., and Asbell, S. O., Deglycosylation of serum vitamin D-binding protein leads to immunosuppression in cancer patients. Cancer Res. 56, 2827-2831, 1996.
13. 13. Yamamoto, N., Homma, S., and Millman, I., Identification of the serum factor required for in vitro activation of macrophages: Role of vitamin D binding protein (group-specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages. J. Immunol. 147, 273-280, 1991.
14. 3 binding protein (group-specific component) is a precursor for the macrophage activating signal factor from lysophosphatidylcholine-treated lymphocytes. Proc. Natl. Acad. Sci. USA 88, 8539-8543, 1991.
15. 3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of β-galactosidase of B cells and sialidase of T cells. J. Immunol. 151, 2794-2802, 1993.
16. 16. Naraparaju, V. R., and Yamamoto, N., Roles ofβ-galactosidase of B lymphocytes and sialidase of T lymphocytes in inflammation-primed activation of macrophages. Immunol. Lett. 43, 143-148, 1994.
17. 3-binding protein in activation of macrophages. J. Immunol. 157, 1744-1751, 1996.
18. 18. Parris, T. M., Kimberly, R. P., Inman, R. D., McDougal, J. S., Gibofsky, A., and Christian, C. L., Defective Fc receptor-mediated function of the mononuclear phagocyte system in lupus nephritis. Ann. Int. Med. 97, 526-532, 1982.
19. 19. Boswell, J., and Schur, P. H., Monocyte function in systemic lupus erythematosus. Clin. Immunol. Immunopathol. 52, 271-278, 1989.
20. 20. Coppenhaver, D. H., Sollenne, N. P., and Bowman, B. H., Post-translational heterogeneity of the human vitamin D-binding protein (group-specific component). Arch. Biochem. Biophys. 226, 218-223, 1983.
21. 21. Viau, M., Constans, J., Debray, H., and Motreuil, J., Isolation and characterization of the O-glycan chain of the human vitamin-D binding protein. Biochem. Biophys. Res. Commun. 117, 324-331, 1983.
22. 3-Sepharose chromatography. Anal. Biochem. 157, 262-269, 1986.
23. 3 binding protein with adjuvant activity for antibody production. Mol. Immunol., 1997.
24. 24. Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., McShane, D. J., Rothfield, N. F., Shaller, J. G., Tald, N., and Winchester, R. J., The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25, 1271-1277, 1982.
25. 25. Yagi, F., Eckhardt, A. E., and Goldstein, I. J., Glycosidases of Ehrlich ascites tumor cells and ascitic fluid-purification and substrate specificity of α-N-acetylgalactosaminidase and α-galactosidase: Comparison with coffee bean α-galactosidase. Arch. Biochem. Biophys. 280, 61-67, 1990.
26. 26. Wang, A. M., and Desnick, R. J., Structural organization and complete sequence of the human α-N-acetylgalactosaminidase gene: Homology with the α-galactosidase A gene provides evidence for evolution from a common ancestral gene. Genomics 10, 133-142, 1991.